Life Sciences Food-as-Medicine Platforms sector
Strategic acquirers, private equity (buyout funds and growth funds) firms, and valuation benchmarks for Life Sciences Food-as-Medicine Platforms
1.1 - About Life Sciences Food-as-Medicine Platforms sector
Companies in the Life Sciences Food-as-Medicine Platforms category develop clinical-grade nutrition solutions and delivery programs that integrate food into care pathways. They combine medical foods, medically tailored meals, and digital tools to prescribe, deliver, and monitor nutrition interventions for specific conditions. By linking evidence-based diets to outcomes data and reimbursement models, these vendors help payers and providers operationalize food as therapy at scale.
Vendors provide end-to-end orchestration for medically tailored meals, handling eligibility, scheduling, logistics, and compliance tracking within care programs. Many supply medical foods and condition-specific formulations supported by clinical evidence, alongside food prescription and benefits administration tools embedded in care management workflows. Advanced capabilities include biomarker and nutrigenomics services to personalize diets, EHR-integrated clinical decision support that surfaces nutrition orders, outcomes analytics that generate real‑world evidence, and APIs that connect payers, providers, and community food vendors.
Primary customers include health systems and integrated provider networks, health plans and payers, and value‑based care organizations. These platforms drive measurable outcomes such as lower total cost of care through reduced readmissions, improved chronic disease control and medication adherence, stronger performance in quality and risk contracts, and better access and equity for populations impacted by social determinants of health.
2. Buyers in the Life Sciences Food-as-Medicine Platforms sector
2.1 Top strategic acquirers of Life Sciences Food-as-Medicine Platforms companies
Virta Health
- Description: Provider of a nutrition-first virtual care platform that uses personalized, science-backed dietary therapy and continuous remote clinical support to help patients reverse type 2 diabetes, achieve sustainable weight loss, and lower medication use; delivered at scale through partnerships with employers and health plans.
- Key Products:
- Diabetes Reversal Program: Virtual clinical program delivering personalized low-carb nutrition therapy, continuous remote monitoring and coaching to reduce or eliminate diabetes medications and reverse type 2 diabetes
- Sustainable Weight Loss Program: Science-backed, individualized nutrition guidance and health-coach support that drives lasting weight loss through lower-carb, whole-food eating and ongoing outcome tracking
- Employer & Health Plan Metabolic Solution: Outcomes-based service that integrates Virta’s diabetes and weight programs into employer or insurer benefits, providing measurable cost savings and health improvements across member populations
- GLP-1 Deprescription Support: Clinical transition service that safely steps members down from GLP-1s or insulin, minimizing risks, monitoring outcomes and sustaining results with nutrition-first, patient-centered care.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
2.2 - Strategic buyer groups for Life Sciences Food-as-Medicine Platforms sector
M&A buyer group 1: Personalized Nutrition
Viome
- Type: N/A
- Employees: ●●●●●
- Description: Provider of direct-to-consumer at-home RNA testing that analyzes microbial and human gene expression to map an individual’s internal biochemistry and microbiome, delivering personalized, adaptive nutrition and health recommendations through technology licensed from Los Alamos National Laboratory.
- Key Products:
- Gut Intelligence™ Test: At-home stool test uses RNA sequencing to analyze microbial gene expression, delivers 20+ gut health scores and food recommendations within 2-3 weeks via the Viome app, identifying inflammation and metabolic issues
- VRx My·Biotics™ Gut Formula: Personalized monthly stick pack blending clinically studied probiotic strains and targeted prebiotic fibers matched to the customer’s microbiome to restore balance, improve digestion and support gut resilience
- Precision Supplements™: Data-driven capsules custom-mixed for each user with up to 50 vitamins, minerals, herbs, enzymes and amino acids at clinically informed dosages to address specific gut and systemic health needs
- Gut Health Solutions Bundle: Integrated program combining the Gut Intelligence Test, optional Precision Supplements and VRx My·Biotics Formula, supported by AI-generated food guidance, to reduce gas, bloating, and support nutrient absorption and gut-brain health.
Buyer group 2: ████████ ████████
●● companiesBuyer group 3: ████████ ████████
●● companies3. Investors and private equity firms in Life Sciences Food-as-Medicine Platforms sector
3.1 - Buyout funds in the Life Sciences Food-as-Medicine Platforms sector
2.2 - Strategic buyer groups for Life Sciences Food-as-Medicine Platforms sector
4 - Top valuation comps for Life Sciences Food-as-Medicine Platforms companies
4.2 - Public trading comparable groups for Life Sciences Food-as-Medicine Platforms sector
Valuation benchmark group 1: Population Health Management Software Companies
Privia Health
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of technology-driven healthcare solutions, optimizing physician practices, enhancing patient experiences, and rewarding doctors for high-value care through collaboration with medical groups, health plans, and health systems.
- Key Products:
- Practice Management: Tools and services to optimize physician practices
- Patient Portal: Platform for patient engagement and communication
- Value-Based Care: Strategies to improve care quality and reduce costs
- Virtual Care: Telehealth services for remote patient consultations
- Fitness and Nutrition Plans: Personalized health assessments and plans for patients